Health Insurance Appeals Process: Patient Rights and Procedures

When a health insurance claim gets denied, that denial is not the final word — and federal law is explicit about that. The appeals process exists as a structured, legally protected pathway for patients to challenge coverage decisions, whether the denial involves a medical procedure, a prescription drug, a hospital admission, or a referral to a specialist. Understanding how that process works, what deadlines govern it, and where the leverage points actually sit can make the difference between a reversed denial and an unchallenged one.

Definition and scope

A health insurance appeal is a formal request for an insurer to reconsider a coverage denial or adverse benefit determination. The Affordable Care Act, through provisions codified at 45 CFR Part 147, established a minimum federal standard requiring insurers to offer at least two levels of internal appeal and, after exhausting those, access to external review by an independent organization.

The scope of appeals rights depends on the type of health plan. Plans regulated under the Employee Retirement Income Security Act of 1974 (ERISA) — which covers most employer-sponsored plans — operate under a different enforcement structure than individual or small-group plans purchased on the ACA marketplaces. State-regulated plans may carry additional protections layered on top of the federal floor. Self-funded employer plans, however, are generally exempt from state insurance law, which is one of those structural quirks that catches patients off guard at the worst possible moment. The key dimensions of patient advocacy section of this site covers that jurisdictional complexity in more detail.

How it works

The federal framework creates a sequential process. Once a denial is issued, the clock starts.

1. Internal Appeal — Level 1: The patient (or an authorized representative) submits a written appeal to the insurer. For non-urgent claims, the insurer has 30 days to respond if the denial involved a pre-service claim, and 60 days for post-service claims, per HHS guidance on internal appeals.
2. Expedited Internal Appeal: For urgent or ongoing care situations, a decision must be rendered within 72 hours of receiving the appeal.
3. Internal Appeal — Level 2: If the first internal appeal fails, a second internal review is triggered, often conducted by a different set of reviewers than those who issued the original denial.
4. External Review: After internal options are exhausted, the patient may request an independent external review. Under the ACA, the external reviewer's decision is binding on the insurer. The Department of Labor's external review guidance outlines the specific timelines and entity standards that apply.
5. State Insurance Commissioner complaint or legal action: If external review fails or is unavailable, escalation to the state insurance commissioner or federal litigation under ERISA remains an option.

Contrast this with Medicare's separate appeals structure, which runs through five distinct levels — from the plan's internal redetermination all the way to Federal District Court — governed by 42 CFR Part 405. The Medicare pathway is meaningfully different from private insurance appeals and should not be conflated with it. For a broader orientation on navigating these systems, how it works provides useful framing.

Common scenarios

Denials cluster around a handful of recurring fact patterns. Prior authorization denials — where an insurer refuses to approve a procedure before it happens — represent one of the most common triggers for appeals. Step therapy protocols, where an insurer requires a patient to fail on a cheaper drug before approving a prescribed one, generate a second major category. Denials based on "medical necessity" determinations make up a third, and these are often the most contested because they pit the insurer's utilization management criteria against the treating physician's clinical judgment.

A fourth scenario involves out-of-network billing disputes, particularly after emergency care where the patient had no practical ability to choose a network provider. The No Surprises Act, effective January 1, 2022, added a separate dispute resolution process for certain balance billing situations, distinct from the standard internal appeals track — a distinction worth understanding before choosing which pathway to pursue.

Patients who feel uncertain about which type of denial they are facing, or how to frame a clinical argument in an appeal letter, often benefit from working with a professional patient advocate. How to get help for patient advocacy outlines what those support structures look like in practice.

Decision boundaries

Appeals succeed or fail along two primary axes: procedural compliance and clinical documentation.

On the procedural side, missing a deadline — the standard window for filing an internal appeal after a denial is typically 180 days under ACA rules — can forfeit appeal rights entirely. Every denial notice is required by law to include the specific reason for the denial, the clinical criteria used, and the instructions for how to appeal. If those disclosures are absent, that omission is itself grounds for a complaint.

On the clinical side, the single most effective element in a successful appeal is a detailed letter of medical necessity from the treating physician, citing peer-reviewed literature and directly addressing the insurer's stated criteria for denial. Insurers' coverage determinations reference specific coverage policies, and an appeal that does not engage with those criteria point-by-point is easy to deny on the same grounds as the first decision.

External reviewers — the independent organizations certified under state or federal standards — reverse insurer decisions at rates that vary by plan type and denial category. A 2023 KFF analysis found that consumers who appeal marketplace plan denials win a majority of those appeals when they reach the external review stage, which is a striking data point given how few patients ever file a first-level internal appeal at all. The patient advocacy frequently asked questions page addresses what patients can realistically expect from each stage of this process.